SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-093271
Filing Date
2021-03-25
Accepted
2021-03-25 06:08:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d158105ddefa14a.htm DEFA14A 19130
2 GRAPHIC g158105na_1.jpg GRAPHIC 204206
3 GRAPHIC g158105na_2.jpg GRAPHIC 117431
  Complete submission text file 0001193125-21-093271.txt   463174
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: DEFA14A | Act: 34 | File No.: 001-39398 | Film No.: 21770029
SIC: 2834 Pharmaceutical Preparations